These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24070851)

  • 1. Foam sclerosants are more stable at lower temperatures.
    Valenzuela GC; Wong K; Connor DE; Behnia M; Parsi K
    Eur J Vasc Endovasc Surg; 2013 Nov; 46(5):593-9. PubMed ID: 24070851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic physiochemical and rheological properties of detergent sclerosants.
    Wong K; Chen T; Connor DE; Behnia M; Parsi K
    Phlebology; 2015 Jun; 30(5):339-49. PubMed ID: 24671525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerosant foam structure and stability is strongly influenced by liquid air fraction.
    Cameron E; Chen T; Connor DE; Behnia M; Parsi K
    Eur J Vasc Endovasc Surg; 2013 Oct; 46(4):488-94. PubMed ID: 23993276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of sclerosant foams by mechanical methods increases the foam temperature.
    Tan L; Wong K; Connor D; Fakhim B; Behnia M; Parsi K
    Phlebology; 2017 Aug; 32(7):501-505. PubMed ID: 27738239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.
    Rao J; Goldman MP
    Dermatol Surg; 2005 Jan; 31(1):19-22. PubMed ID: 15720090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative stability of sodium tetradecyl sulphate (STD) and polidocanol foam: impact on vein damage in an in-vitro model.
    McAree B; Ikponmwosa A; Brockbank K; Abbott C; Homer-Vanniasinkam S; Gough MJ
    Eur J Vasc Endovasc Surg; 2012 Jun; 43(6):721-5. PubMed ID: 22507925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foam bubble size is significantly influenced by sclerosant concentration for polidocanol but not sodium tetradecyl sulphate.
    Wong K; Connor DE; Andrade OC; Parsi K
    Phlebology; 2021 Aug; 36(7):576-587. PubMed ID: 33736561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation on the influence of glycerin on sclerosant foam stability.
    Peterson JD; Goldman MP
    Phlebology; 2011 Sep; 26(6):232-4. PubMed ID: 21415429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy?
    Lai SW; Goldman MP
    J Drugs Dermatol; 2008 Apr; 7(4):399-400. PubMed ID: 18459524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium tetradecyl sulphate foam stability prior to injection: factors affecting liquid reformation.
    McMaster S
    Phlebology; 2011 Sep; 26(6):222-6. PubMed ID: 21415426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polidocanol foam stability in terms of its association with glycerin.
    Rial R; Hervas LS; Monux G; Galindo A; Martin A; Hernando M; Martinez I; Hernando A; Serrano FJ
    Phlebology; 2014 Jun; 29(5):304-9. PubMed ID: 23470491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiochemical properties and reproducibility of air-based sodium tetradecyl sulphate foam using the Tessari method.
    Watkins MR; Oliver RJ
    Phlebology; 2017 Jul; 32(6):390-396. PubMed ID: 27329670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Different Mixing Agents on the Stability of Sodium Tetradecyl Sulfate (STS) Foam: An Experimental Study.
    Hashimoto K; Uchida B; Horikawa M; Mimura H; Farsad K
    Cardiovasc Intervent Radiol; 2018 Dec; 41(12):1952-1957. PubMed ID: 30088060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sulodexide on stability of sclerosing foams.
    Critello CD; Fiorillo AS; Cristiano MC; de Franciscis S; Serra R
    Phlebology; 2019 Apr; 34(3):191-200. PubMed ID: 29871533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.
    Bush R; Bush P
    Phlebology; 2017 Aug; 32(7):496-500. PubMed ID: 27738241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of Sclerosing Foam Stability in the Treatment of Varicose Veins.
    Bai T; Liu Y; Jiang W; Li Y; Liu J; Yu C; Fan Y
    Dermatol Surg; 2020 Feb; 46(2):249-257. PubMed ID: 31569112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles.
    Parsi K; Exner T; Connor DE; Ma DD; Joseph JE
    Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):731-40. PubMed ID: 17919946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Investigation on the Influence of Hyaluronic Acid on Polidocanol Foam Stability.
    Chen AW; Liu YR; Li K; Liu SH
    Dermatol Surg; 2016 Jan; 42(1):56-8. PubMed ID: 26671207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.
    Carugo D; Ankrett DN; Zhao X; Zhang X; Hill M; O'Byrne V; Hoad J; Arif M; Wright DD; Lewis AL
    Phlebology; 2016 May; 31(4):283-95. PubMed ID: 26036246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation into the influence of various gases and concentrations of sclerosants on foam stability.
    Peterson JD; Goldman MP
    Dermatol Surg; 2011 Jan; 37(1):12-7. PubMed ID: 21199095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.